CRYO CELL INTERNATIONAL INC
Financial highlights
| Metric | FY 11/30/25 | FY 11/30/24 | FY 11/30/23 | FY 11/30/22 | FY 11/30/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $31.6M | $32.0M | $31.3M | $30.3M | $28.9M |
| Cost of revenue | $7.4M | $7.9M | $8.4M | $8.8M | $9.0M |
| Selling, general & administrative | $18.2M | $18.5M | $17.2M | $15.6M | $14.6M |
| Research and development | $376,263 | $1.2M | $1.2M | $384,789 | $49,870 |
| Operating income | $482,394 | $3.5M | -$12.3M | $4.0M | $4.0M |
| Interest expense | $2.1M | $1.9M | $1.2M | $1.5M | $1.4M |
| Pretax income | -$2.3M | $2.8M | -$13.4M | $3.3M | $2.6M |
| Income tax expense | $92,232 | $2.4M | -$3.8M | $547,540 | $527,710 |
| Net income | -$2.4M | $402,095 | -$9.5M | $2.8M | $2.1M |
| Balance Sheet | |||||
| Cash and equivalents | $319,031 | $560,960 | $406,067 | $1.7M | $8.3M |
| Current assets | $11.8M | $12.6M | $9.5M | $9.6M | $15.8M |
| Total assets | $61.7M | $64.7M | $61.2M | $64.9M | $60.7M |
| Current liabilities | $19.8M | $21.6M | $20.9M | $19.5M | $21.1M |
| Total liabilities | $80.3M | $77.9M | $72.3M | $66.4M | $56.5M |
| Stockholders' equity | -$18.6M | -$13.2M | -$11.0M | -$1.5M | $4.2M |
| Cash Flow Statement | |||||
| Cash from operations | $5.5M | $6.0M | $8.9M | $8.6M | $7.9M |
| Depreciation and amortization | $985,242 | $693,847 | $1.4M | $1.5M | $1.0M |
| Stock-based compensation | $417,101 | $781,128 | $816,639 | $461,345 | $301,616 |
| Capital expenditure | $230,475 | $2.4M | $6.8M | $12.2M | $1.8M |
| Free cash flow | $5.2M | $3.6M | $2.1M | -$3.6M | $6.1M |
| Dividends paid | $3.2M | $2.0M | $0 | $7.7M | $0 |
| Share repurchases | $169,502 | $1.4M | $799,036 | $1.8M | $249,377 |
| Impairments | — | $0 | $0 | $0 | $0 |
Shares outstanding 8.1M · Free float 4.6%
Annual filing data through FY ended November 30, 2025; float as of July 11, 2026.